Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment-Reference-Cited by-同舟云学术

Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment

Published:2016-06 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Noguera-Ortega Estela,Blanco-Cabra Núria,Rabanal Rosa Maria,Sánchez-Chardi Alejandro,Roldán Mónica,Guallar-Garrido Sandra,Torrents Eduard,Luquin Marina,Julián Esther

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep27232.pdf

Reference51 articles.

1. van Rhijn, B. W. G. et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur. Urol. 56, 430–42 (2009).

2. Patel, S. G., Cohen, A., B, W. A. & Steinberg, G. D. Intravesical therapy for bladder cancer. Expert Opin. Pharmacother. 16, 889–901 (2015).

3. Gandhi, N. M., Morales, A. & Lamm, D. L. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer. BJU Int. 112, 288–97 (2013).

4. Lamm, D. L. Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer. Clin. Infect. Dis. 31 Suppl 3, S86–90 (2000).

5. Luquin, M. et al. Mycobacterium brumae sp. nov., a Rapidly Growing, Nonphotochromogenic Mycobacterium. Int. J. Syst. Bacteriol. 43, 405–413 (1993).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urease-powered nanobots for radionuclide bladder cancer therapy;Nature Nanotechnology;2024-01-15

2. Radionuclide therapy based on accumulated urease-powered nanobots in the bladder tumor of an orthotopic murine model;2023-03-28

3. Genomic analysis of Mycobacterium brumae sustains its nonpathogenic and immunogenic phenotype;Frontiers in Microbiology;2023-01-05

4. Genomic analysis ofMycobacterium brumaesustains its nonpathogenic and immunogenic phenotype;2022-12-02

5. Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-γ/IL-17 release in bladder cancer treatment;OncoImmunology;2022-03-23